Leonard Sank Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

ORMP Quotes by TradingView

Leonard Sank is Director of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 98,021 shares of ORMP, which is worth approximately $226,428. The most recent transaction as insider was on Jan 04, 2024, when has been sold 39,325 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 98K
0% 3M change
67.0% 12M change
Total Value Held $226,428

Leonard Sank Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2024
BUY
Grant, award, or other acquisition
-
39,325 Added 28.63%
98,021 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 33.82%
58,696 Common Stock
Aug 08 2022
SELL
Payment of exercise price or tax liability
$81,596 $8.77 p/Share
9,304 Reduced 24.48%
28,696 Common Stock
Aug 08 2022
BUY
Exercise of conversion of derivative security
$81,600 $4.08 p/Share
20,000 Added 34.48%
38,000 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 40.0%
18,000 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
6,000 Added 50.0%
6,000 Common Stock
LS

Leonard Sank

Director
Cape Town, T3

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORMP